TERT antibody (Telomerase Reverse Transcriptase) (C-Term)

Details for Product anti-TERT Antibody No. ABIN1450190, Supplier: Log in to see
Antigen
  • Tert
  • tert
  • CMM9
  • DKCA2
  • DKCB4
  • EST2
  • PFBMFT1
  • TCS1
  • TP2
  • TRT
  • hEST2
  • hTRT
  • TR
  • chTERT
  • ATTERT
  • F5E19.190
  • F5E19_190
  • telomerase reverse transcriptase
  • Telomerase Reverse Transcriptase
  • telomerase reverse transcriptase
  • Telomerase catalytic subunit
  • trt-1
  • Tert
  • tert
  • TRT1
  • CMU_003490
  • VDBG_04487
  • GL50803_16225
  • TERT
Alternatives
anti-Human TERT antibody for Dot Blot
Epitope
C-Term, AA 1104-1123
35
18
16
15
15
14
14
11
9
9
7
7
7
6
6
5
5
5
4
4
4
3
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
236
78
52
18
4
3
Host
Rabbit
235
14
10
1
Clonality
Polyclonal
Conjugate
This TERT antibody is un-conjugated
16
15
13
7
6
6
4
4
3
3
3
3
3
3
3
3
3
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF), Immunoprecipitation (IP), Western Blotting (WB)
149
116
44
40
39
37
24
19
18
13
8
4
4
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen Synthetic peptide corresponding to amino acids 1104-1123 of the carboxy terminal end of Human TERT
Sequence S-R-K-L-P-G-T-T-L-T-A-L-E-A-A-A-N-P-A-L Remarks: Accession Number: AF018167
Specificity This antiserum primarily detects Human TERT, but several non-specific bands appear on immunoblots (Figure 1). In Immunofluorescence Microscopy assays, staining with anti-TERT-16 was specific to the nuclei of cells with ectopic TERT expression.
Cross-Reactivity (Details) Species reactivity (tested):Human.
Purification Affinity Chromatography
Alternative Name TERT (TERT Antibody Abstract)
Background Telomerase is a reverse transcriptase that adds telomeric repeats (TTAGGG)n to chromosomal ends, compensating for the telomere shortening that occurs with DNA replication. In normal human somatic cells, telomerase is repressed and telomeres progressively shorten, leading to limited lifespan and senescence. Reactivation of telomerase activity is associated with human cancer and cell immortalization. Approximately 85 % of human cancers, including breast, prostate, stomach, bladder, colon, and liver cancer, have telomerase activity, whereas most normal somatic cells do not. The specificity of telomerase to human cancer has led to investigations of telomerase activity and expression as a tumor marker. For example, the presence of telomerase activity in human urine has been identified as a marker for human bladder carcinoma. Human telomerase consists of three major subunits: a catalytic protein subunit called hTERT (for human TElomerase Reverse Transcriptase), a template RNA called hTR, and telomerase-associated protein (TEP-1). TERT and hTR are minimally required to reconstitute telomerase activity in vitro. In human cells, hTR is constitutively expressed. TERT transcription is a primary mechanism for regulation of telomerase activity.Synonyms: EST2, HEST2, TCS1, TRT, Telomerase catalytic subunit, Telomerase reverse transcriptase, Telomerase-associated protein 2
Gene ID 7015
NCBI Accession NP_001180305
UniProt O14746
Research Area DNA/RNA, Cell Cycle, Enzymes
Pathways Telomere Maintenance
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Concentration 1.0 mg/mL (by UV absorbance at 280 nm).
Buffer 0.02 M Potassium Phosphate, 0.12 M Sodium Chloride, pH 7.2, 0.01 % (w/v) Sodium Azide, None
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the lyophilized product at 2-8 °C. Following reconstitution store in aliquots at -20 °C.
Product cited in: van den Akker, Surtel, Cremers, Rodrigues-Pinto, Richardson, Hoyland, van Rhijn, Welting, Voncken: "Novel immortal human cell lines reveal subpopulations in the nucleus pulposus." in: Arthritis research & therapy, Vol. 16, Issue 3, pp. R135, 2014 (PubMed).

Ahmed, Passos, Birket, Beckmann, Brings, Peters, Birch-Machin, von Zglinicki, Saretzki: "Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress." in: Journal of cell science, Vol. 121, Issue Pt 7, pp. 1046-53, 2008 (PubMed).

Background publications Wu, Dudognon, Nguyen, Hillion, Pendino, Tarkanyi, Aradi, Lanotte, Tong, Chen, Ségal-Bendirdjian: "Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths." in: Journal of cell science, Vol. 119, Issue Pt 13, pp. 2797-806, 2006 (PubMed).

Shay, Zou, Hiyama, Wright: "Telomerase and cancer." in: Human molecular genetics, Vol. 10, Issue 7, pp. 677-85, 2001 (PubMed).

Drissi, Zindy, Roussel, Cleveland: "c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells." in: The Journal of biological chemistry, Vol. 276, Issue 32, pp. 29994-30001, 2001 (PubMed).